Distalmotion

Key facts

Product

Dexter hybrid laparoscopic surgical robot (robotic <-> manual mid-procedure); ASC cost-efficiency.

Gating events

CE Dec 2020; FDA De Novo Oct 2024 (inguinal hernia) + cholecystectomy + hysterectomy.

Models (1)

• Dextersurgical

Supplies to

No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company’s outbound edges.

Outbound supply edges from this company. Each relationship appears here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.

Sources (4)

1. https://www.biospace.com/distalmotion-dexter-fda-de-novo ↗
2. https://www.bioworld.com/articles/distalmotion-ce-mark-dexter ↗
3. https://www.globenewswire.com/news-release/2025/11/18/distalmotion-150-million ↗
4. https://www.massdevice.com/distalmotion-dexter-fda-clearance/ ↗

Common questions

What is Distalmotion?

Swiss surgical-robotics company (Lausanne; EPFL spinout, founded 2012) making the Dexter hybrid laparoscopic robot; CE 2020, FDA De Novo 2024 + two more indications; ~3,000 patients.

Where is Distalmotion based?

Distalmotion is based in Lausanne, Switzerland.

When was Distalmotion founded?

Distalmotion was founded in 2012.

What does Distalmotion make?

Distalmotion has 1 robot model on the DEPLOY registry: Dexter (Distalmotion builds both physical robots and the AI that runs them).

Where does Distalmotion operate robots?

Distalmotion is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.